Grasela T H, Watkins W D, Hug C C, McLeskey C H, Nahrwold M L, Roizen M F, Stanley T H, Thisted R A, Walawander C A, White P F
Center for Pharmacoepidemiology Research, State University of New York at Buffalo 14260.
Anesth Analg. 1993 Oct;77(4 Suppl):S44-50.
Despite tremendous efforts to ensure the safety and effectiveness of newly marketed medications, a number of these have had significant problems after introduction of the drug to the market. Such problems highlight the practical limitations of clinical trials performed to obtain FDA approval for marketing. Pharmacoepidemiology research methodologies provide a powerful mechanism for exploring the determinants of drug safety and effectiveness in broad-based populations and can serve as a scientific foundation for outcome research. Using these methodologies, largescale postmarketing surveillance studies similar to the type described in the accompanying articles would constitute an important way of confirming and identifying the determinants of drug safety and effectiveness in large, diverse patient populations.
尽管为确保新上市药物的安全性和有效性付出了巨大努力,但其中一些药物在上市后仍出现了重大问题。这些问题凸显了为获得美国食品药品监督管理局(FDA)上市批准而进行的临床试验的实际局限性。药物流行病学研究方法为探索广泛人群中药物安全性和有效性的决定因素提供了有力机制,并且可以作为结果研究的科学基础。使用这些方法,类似于随附文章中描述类型的大规模上市后监测研究将成为在庞大、多样的患者群体中确认和识别药物安全性和有效性决定因素的重要方式。